Sherwin-Williams (NYSE:SHW) PT Raised to $360.00

Sherwin-Williams (NYSE:SHW) had its target price raised by equities research analysts at Robert W. Baird from $350.00 to $360.00 in a research note issued on Wednesday, Benzinga reports. The firm currently has a “neutral” rating on the specialty chemicals company’s stock. Robert W. Baird’s price target would indicate a potential downside of 0.44% from the company’s previous close.

SHW has been the subject of a number of other reports. Barclays upped their target price on shares of Sherwin-Williams from $315.00 to $355.00 and gave the stock an “equal weight” rating in a research note on Wednesday, July 24th. The Goldman Sachs Group increased their price objective on Sherwin-Williams from $344.00 to $390.00 and gave the stock a “buy” rating in a report on Wednesday, July 24th. Morgan Stanley boosted their target price on Sherwin-Williams from $375.00 to $450.00 and gave the company an “overweight” rating in a research note on Friday, October 18th. BMO Capital Markets raised their price target on shares of Sherwin-Williams from $400.00 to $425.00 and gave the stock an “outperform” rating in a research note on Monday, September 30th. Finally, Wells Fargo & Company lifted their price objective on shares of Sherwin-Williams from $350.00 to $400.00 and gave the company an “equal weight” rating in a report on Tuesday, October 15th. One analyst has rated the stock with a sell rating, six have assigned a hold rating, thirteen have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $395.29.

Sherwin-Williams Trading Down 0.3 %

NYSE SHW opened at $361.59 on Wednesday. Sherwin-Williams has a one year low of $232.06 and a one year high of $392.57. The company has a debt-to-equity ratio of 1.97, a current ratio of 0.83 and a quick ratio of 0.50. The firm has a market cap of $91.68 billion, a P/E ratio of 38.55, a P/E/G ratio of 2.87 and a beta of 1.17. The stock’s 50-day moving average is $371.81 and its 200-day moving average is $334.64.

Sherwin-Williams (NYSE:SHW) last announced its earnings results on Tuesday, October 22nd. The specialty chemicals company reported $3.37 EPS for the quarter, missing the consensus estimate of $3.56 by ($0.19). The company had revenue of $6.16 billion for the quarter, compared to analyst estimates of $6.20 billion. Sherwin-Williams had a return on equity of 74.45% and a net margin of 11.09%. The business’s quarterly revenue was up .7% on a year-over-year basis. During the same quarter last year, the business posted $3.20 earnings per share. Sell-side analysts anticipate that Sherwin-Williams will post 11.31 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Sherwin-Williams news, CFO Allen J. Mistysyn sold 14,520 shares of the firm’s stock in a transaction on Friday, August 30th. The stock was sold at an average price of $366.83, for a total transaction of $5,326,371.60. Following the completion of the sale, the chief financial officer now owns 63,520 shares of the company’s stock, valued at $23,301,041.60. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.60% of the stock is owned by insiders.

Institutional Investors Weigh In On Sherwin-Williams

Several hedge funds have recently bought and sold shares of SHW. Brookstone Capital Management increased its holdings in shares of Sherwin-Williams by 20.6% during the first quarter. Brookstone Capital Management now owns 4,732 shares of the specialty chemicals company’s stock worth $1,644,000 after purchasing an additional 808 shares during the period. Wealthcare Advisory Partners LLC bought a new position in shares of Sherwin-Williams in the 1st quarter valued at $231,000. Procyon Advisors LLC boosted its holdings in shares of Sherwin-Williams by 4.4% during the 1st quarter. Procyon Advisors LLC now owns 3,007 shares of the specialty chemicals company’s stock valued at $1,044,000 after acquiring an additional 128 shares in the last quarter. Fifth Third Wealth Advisors LLC grew its position in Sherwin-Williams by 6.3% during the 1st quarter. Fifth Third Wealth Advisors LLC now owns 1,210 shares of the specialty chemicals company’s stock worth $420,000 after acquiring an additional 72 shares during the last quarter. Finally, Register Financial Advisors LLC acquired a new position in Sherwin-Williams in the 1st quarter worth about $120,000. 77.67% of the stock is currently owned by institutional investors and hedge funds.

About Sherwin-Williams

The Sherwin-Williams Company engages in the development, manufacture, distribution, and sale of paints, coating, and related products to professional, industrial, commercial, and retail customers. It operates through three segments: Paint Stores Group, Consumer Brands Group, and Performance Coatings Group.